A detailed history of Mml Investors Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mml Investors Services, LLC holds 1,387,138 shares of PFE stock, worth $37.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,387,138
Previous 1,333,652 4.01%
Holding current value
$37.1 Million
Previous $37.3 Million 7.58%
% of portfolio
0.15%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$27.7 - $31.39 $1.48 Million - $1.68 Million
53,486 Added 4.01%
1,387,138 $40.1 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $2.19 Million - $2.57 Million
86,684 Added 6.95%
1,333,652 $37.3 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $2.09 Million - $2.4 Million
80,619 Added 6.91%
1,246,968 $34.6 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $4.35 Million - $5.65 Million
166,587 Added 16.66%
1,166,349 $33.6 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $2.2 Million - $2.57 Million
68,579 Added 7.36%
999,762 $33.2 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $4.97 Million - $5.75 Million
137,616 Added 17.34%
931,183 $34.2 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $1.06 Million - $1.38 Million
-26,827 Reduced 3.27%
793,567 $32.4 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $2.86 Million - $3.74 Million
68,591 Added 9.12%
820,394 $42 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.75 Million - $2.14 Million
40,020 Added 5.62%
751,803 $32.9 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $140,241 - $166,282
3,014 Added 0.43%
711,783 $37.3 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $1.14 Million - $1.42 Million
25,019 Added 3.66%
708,769 $36.7 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $212,632 - $315,192
-5,146 Reduced 0.75%
683,750 $40.4 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $247,942 - $318,503
-6,317 Reduced 0.91%
688,896 $29.6 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.02 Million - $1.15 Million
28,301 Added 4.24%
695,213 $27.2 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.33 Million - $1.5 Million
39,806 Added 6.35%
666,912 $24.2 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $4.41 Million - $5.61 Million
131,903 Added 26.64%
627,106 $23.1 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $1.41 Million - $1.66 Million
44,480 Added 9.87%
495,203 $18.2 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $946,249 - $1.15 Million
31,416 Added 7.49%
450,723 $14 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $2.61 Million - $3.72 Million
-96,397 Reduced 18.69%
419,307 $13 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $2.2 Million - $2.5 Million
66,954 Added 14.92%
515,704 $20.2 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $311,546 - $403,984
-9,589 Reduced 2.09%
448,750 $16.1 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $1.01 Million - $1.13 Million
27,265 Added 6.32%
458,339 $19.9 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $2.21 Million - $2.43 Million
58,948 Added 15.84%
431,074 $18.3 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $2.05 Million - $2.34 Million
-53,343 Reduced 12.54%
372,126 $16.2 Million
Q3 2018

Nov 07, 2018

BUY
$34.47 - $41.81 $3.62 Million - $4.4 Million
105,161 Added 32.83%
425,469 $18.8 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $502,351 - $535,557
15,232 Added 4.99%
320,308 $11.6 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $999,102 - $1.16 Million
-31,310 Reduced 9.31%
305,076 $10.8 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $1.49 Million - $1.58 Million
-44,740 Reduced 11.74%
336,386 $12.2 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $11.8 Million - $13 Million
381,126
381,126 $13.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.